Vumerity TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: diroximel fumarate
Pack: Vumerity 231 mg enteric capsule, 120, bottle
Brand name
(ARTG)
: VUMERITY diroximel fumarate 231 mg enteric capsules bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
VUMERITY is indicated in patients with relapsing multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule, enteric
- Oral
- White capsules printed with DRF 231 mg in black ink on the capsule body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Protect from Moisture
- Store in Original Container
- Shelf lifetime is 32 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 120 capsules pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient diroximel fumarate
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
